StockKit ResearchEQUITY RESEARCH BRIEF
300760 · CN · Cached
Generated 2026-06-19 02:02 UTC
迈瑞医疗
300760 · CN
¥140.01
-2.33%
Technical posture
Neutral
Strategy score
49 / 100
Trend
consolidation
Data confidence
Medium
Research view
300760 Research Preview
1. Bottom line
- Current setup: 迈瑞医疗 (300760) is in a consolidation, trading at 140.01 (-2.33%), sitting at the very bottom of its 30-session range (172.67 high to 140.01 low, position +0.00%) and roughly 4.87% below MA20. The strategy score is 49/100 with a Hold signal, balancing an oversold short-term posture against visible distribution.
- Confidence: Medium on technicals (full indicator set supplied), low on fundamentals and sentiment (no valuation, news, or social data returned).
- Most important level to monitor: the estimated support / lower Bollinger band at 138.36 (just 1.18% below price). Holding above it keeps a mean-reversion bounce in play; a decisive break opens fresh range lows with no nearby supplied support beneath.
02Key data snapshot
| Metric | Reading |
|---|---|
| Price | 140.01 |
| Daily move | -2.33% |
| Strategy score | 49/100 (Hold) |
| Trend | Consolidation |
| RSI14 / RSI6 | 34.39 / 30.87 |
| MACD (line / signal / hist) | -4.23 / -4.29 / 0.07 |
| Support (est.) | 138.36 (+1.18% below price... i.e. price is +1.18% above support) |
| Resistance (est.) | 156.01 (+11.43% above price) |
| 30-session range position | +0.00% (at range low) |
| Data confidence | Technicals: medium; Fundamentals & sentiment: low |
03Technical indicator panel
| Indicator | Reading | Read |
|---|---|---|
| MA (5/10/20/60) | 144.76 / 144.36 / 147.18 / 157.49 | Price below all MAs; MA20 and MA60 sloping down. Note conflict: supplied context labels this "MA5 > MA10 > MA20 > MA60", but the values show MA10 (144.36) below MA20 (147.18), and the score module flags a MA5<MA20 death cross (40/100). Treated as a bearish-to-neutral alignment. |
| RSI (14/6) | 34.39 / 30.87 | Soft but not washed out; RSI6 near the lower zone. Score module reads this as mildly oversold (60/100, Buy bias). |
| MACD | -4.23 / -4.29 / 0.07 | Conflicted: the line sits well below the zero axis (downtrend momentum), yet the histogram is marginally positive (0.07) and the module flags a golden cross with fading momentum. Below-zero crosses are lower-conviction. |
| KDJ (K/D/J) | 22.45 / 30.86 / 5.61 | Low and still repairing; J at 5.61 is depressed, consistent with a stretched short-term move rather than confirmed reversal. |
| Bollinger (U/M/L) | 156.01 / 147.18 / 138.36 | Price near the lower band (~9% of band width). Module reads possible bounce (60/100). Lower band coincides with estimated support. |
| ATR14 / ATR14% | 3.85 / +2.75% | Moderate volatility; expect roughly a ~3.85-point daily swing as a planning gauge. |
| OBV / 20-session slope | -119,172,449 / -41.14% | Distribution pressure visible; the steep negative slope is the clearest bearish confirmation in the panel. |
| CCI20 | -96.38 | Inside a neutral-to-soft band, near but not beyond the -100 oversold threshold. |
Confirmed: downside pressure is corroborated by OBV's negative slope, price below all MAs, and the position at the 30-session low. Conflicted: MACD (below zero but positive histogram / claimed golden cross) and the MA-alignment label versus the death-cross score flag. Oversold short-term readings (RSI, KDJ, lower-band proximity) argue for a possible bounce but are not yet confirmed by volume. Missing: no custom indicators were supplied beyond the standard panel.
04Valuation matrix
No configured fundamentals source returned usable valuation data for this symbol. PE, PB, EV/EBITDA, PEG proxy, StockKit fair-value range, and sector context were all N/A (AkShare / EODHD fallback, low confidence), so no valuation rows can be populated. This section therefore carries low confidence, and the brief draws no fundamental conclusion.
05News and catalyst timeline
| Item | Status | Why it matters |
|---|---|---|
| Headline coverage | No current news items available from the configured source | No confirmed catalysts to anchor a fundamental view; price action is interpreted on technicals alone. |
| Catalyst timeline | Missing | Earnings dates, guidance, or corporate events were not supplied and are not assumed. |
No company facts or events are inferred where the source returned nothing. This section is low confidence.
06Sentiment radar
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | No headlines | No source distribution available | Low |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
No Reddit, X, StockTwits, or local-forum readings are created, as no source is marked connected. Sentiment cannot inform the view here.
07Scenario framework
| Scenario | Trigger condition | What would confirm it | What would invalidate it |
|---|---|---|---|
| Base (consolidation) | Price oscillates between support 138.36 and MA5/MA10 (~144.4-144.8) | Range holds with ATR-sized swings (~3.85 pts); OBV slope flattens from -41.14% | Sustained close below 138.36 or above 147.18 (MA20) |
| Upside (oversold bounce) | Defense of 138.36 with RSI14 lifting off 34.39 and KDJ J recovering from 5.61 | Reclaim of MA20 at 147.18 on rising volume; MACD line turning up toward zero | Failure at MA5/MA10 cluster (~144.4-144.8) and rollover back to range low |
| Downside (range break) | Decisive break of 138.36 / lower Bollinger band | Continued negative OBV slope and price-down-on-volume (current 1.2x avg) extending | Quick recovery back above 138.36 and into the prior range |
08Risk matrix
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Distribution / supply overhang | OBV -119.17M, 20-session slope -41.14%; price-down-on-volume (1.2x avg), volume +19.64% vs 20-session average | OBV slope steepens while price probes 138.36 | Watch OBV slope and daily volume vs the 8,761,091 average |
| Range-low breakdown | Price at 30-session low (140.01), position +0.00%; only 1.18% above support | Close below 138.36 | Track the 138.36 support / lower-band level daily |
| Downtrend continuation | Price below MA20 (-4.87%) and MA60 (157.49) sloping down; MA5<MA20 death-cross flag (40/100) | Failure to reclaim MA20 at 147.18 | Monitor MA20 reclaim attempts |
| Indicator conflict / low conviction | MACD below zero (-4.23) yet positive histogram (0.07); MA-alignment label disagrees with death-cross flag | Histogram rolls back negative | Treat MACD bounce signals as low-conviction until line approaches zero |
| Data gaps | No valuation, news, or sentiment returned (all low confidence) | New data source connects | Re-evaluate fundamentals once valuation/news feeds populate |
9. Seven-day watch checklist
1. Support 138.36 / lower Bollinger band - hold vs decisive break (highest priority).
2. OBV 20-session slope (currently -41.14%) - watch for flattening or further deterioration.
3. Daily volume vs 20-session average (8,761,091); current run is +19.64% above and price-down on 1.2x - confirm whether selling persists.
4. MA20 at 147.18 - any reclaim attempt would shift the near-term posture.
5. RSI14 (34.39) and RSI6 (30.87) - look for an upturn off soft levels.
6. KDJ J (5.61) and MACD histogram (0.07) - track whether the tentative short-term repair gains traction.
7. New catalysts or valuation/sentiment data filling current gaps - none supplied today.
Information-use note
This brief is generated from a single supplied dataset for 300760 (迈瑞医疗) and is public-facing research, not personalized investment advice. Technical readings carry medium confidence; valuation, news, and sentiment carry low confidence because the configured sources returned no usable data. All levels are watch levels for observation, not instructions to act, and no returns are implied or promised.
Strategy factors
MA交叉Neutral
40
MA5<MA20死叉
MACD背离Neutral
50
MACD金叉，MACD在零轴下方，动能减弱
RSI极值Constructive
60
RSI14=34偏低
布林带Constructive
60
接近下轨，可能反弹
量价关系Weak
35
价跌放量(1.2x)，抛压沉重
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.
Disclaimer.This brief is generated by StockKit AI from public market data and algorithmic models for informational research only. It is not investment advice, an offer, or a solicitation, and it does not provide buy, sell, or hold ratings, price targets, stop-loss levels, or position sizing. “Watch levels” and “scenarios” describe observable conditions in the supplied data, not instructions. Verify all information with primary sources before any investment decision.